Action PCSA PROCESSA PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Processa Pharmaceuticals, Inc.

Actions

PCSA

US74275C3043

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
2,15 USD -11,52 % Graphique intraday de Processa Pharmaceuticals, Inc. +36,08 % -67,87 %
26/04 Principales baisses du prémarché MT
25/04 Les plus fortes hausses de la mi-journée MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Top Premarket Decliners
Top Midday Gainers
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Processa Pharmaceuticals, Inc. Presents Two Abstracts At the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1B Trial
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
Sector Update: Health Care Stocks Stronger Late Afternoon
Top Midday Decliners
Sector Update: Health Care Stocks Higher Friday Afternoon
Processa Pharmaceuticals Prices $7 Million Common Stock Offering
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Sector Update: Health Care Stocks Softer Late Afternoon
Top Midday Gainers
Processa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatment
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PCSA
  4. Actualités Processa Pharmaceuticals, Inc.
  5. Autres langues